HL
HLS Therapeutics Inc.
HLTRF · OTC
$2.82 +0.00% (+$0.00)
1M +3.30%
Market Cap $88.2M
P/E Ratio -
Div. Yield -
ROE 14.43%
Bulios Fair Price
$3.42
21.3% upside
Trenutna cena
$2.82
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica HLTRF trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
98 /100
Cheap P/S 1.57x
P/B 1.60x
P/FCF 4.98x
Growth
39 /100
Stable FCF growth 32.51%
Book val. growth 21.10%
Rev. growth 2.79%
Profitability
50 /100
Moderate Net margin 15.20%
Op. margin 7.95%
FCF margin 31.49%
Quality
5 /100
Poor ROE 14.43%
ROA 6.66%
Asset turnover 0.44x
Debt
52 /100
Moderate Current ratio 1.05x
Int. coverage -0.75x
Net debt/EBITDA 1.54x
Stability
77 /100
Stable Rev. volatility 6.74%
EPS volatility 27.87%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o HLTRF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Craig Stuart Millian
Employees
85
Headquarters
Etobicoke
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report